Terms: = Lung cancer AND TOP2A, TOP2, TP2A AND Diagnosis
18 results:
1. Predicting potential therapeutic targets and small molecule drugs for early-stage lung adenocarcinoma.
Yu Y; Li L; Luo B; Chen D; Yin C; Jian C; You Q; Wang J; Fang L; Cai D; Sun J
Biomed Pharmacother; 2024 May; 174():116528. PubMed ID: 38555814
[TBL] [Abstract] [Full Text] [Related]
2. Association of top2a and ADH1B with lipid levels and prognosis in patients with lung adenocarcinoma and squamous cell carcinoma.
Yin D; Zhang Y; Li H; Cheng L
Clin Respir J; 2023 Dec; 17(12):1301-1315. PubMed ID: 37985446
[TBL] [Abstract] [Full Text] [Related]
3. Identification of pivotal genes with prognostic evaluation value in lung adenocarcinoma by bioinformatics analysis.
Wang Y; Wang R; Ma J; Wang T; Ma C; Gu Y; Xu Y; Wang Y
Cell Mol Biol (Noisy-le-grand); 2023 Aug; 69(8):221-225. PubMed ID: 37715381
[TBL] [Abstract] [Full Text] [Related]
4. diagnosis and Prognosis of Non-small Cell lung cancer based on Machine Learning Algorithms.
Zhou Y; Dong Y; Sun Q; Fang C
Comb Chem High Throughput Screen; 2023; 26(12):2170-2183. PubMed ID: 36627791
[TBL] [Abstract] [Full Text] [Related]
5. Identification of a five genes prognosis signature for triple-negative breast cancer using multi-omics methods and bioinformatics analysis.
Ma J; Chen C; Liu S; Ji J; Wu D; Huang P; Wei D; Fan Z; Ren L
Cancer Gene Ther; 2022 Nov; 29(11):1578-1589. PubMed ID: 35474355
[TBL] [Abstract] [Full Text] [Related]
6. [Screening of differentially expressed genes for colorectal cancer and prediction of potential traditional Chinese medicine: based on bioinformatics].
Yun ZJ; Wang HJ; Yu YX; Sun ZY; Yao SK
Zhongguo Zhong Yao Za Zhi; 2022 Mar; 47(6):1666-1676. PubMed ID: 35347966
[TBL] [Abstract] [Full Text] [Related]
7. Identification and Integrate Analysis of Key Biomarkers for diagnosis and Prognosis of Non-Small Cell lung cancer Based on Bioinformatics Analysis.
Gong K; Zhou H; Liu H; Xie T; Luo Y; Guo H; Chen J; Tan Z; Yang Y; Xie L
Technol Cancer Res Treat; 2021; 20():15330338211060202. PubMed ID: 34825846
[No Abstract] [Full Text] [Related]
8. KIAA0101 in Malignant Pleural Mesothelioma: A Potential Diagnostic and Prognostic Marker.
Lin P; Zhao Y; Li X; Liang Z
Comb Chem High Throughput Screen; 2022; 25(9):1498-1506. PubMed ID: 34238152
[TBL] [Abstract] [Full Text] [Related]
9. Targeted Luminescent Probes for Precise Upconversion/NIR II Luminescence diagnosis of lung Adenocarcinoma.
Lv R; Wang Y; Lin B; Peng X; Liu J; Lü WD; Tian J
Anal Chem; 2021 Mar; 93(11):4984-4992. PubMed ID: 33705098
[TBL] [Abstract] [Full Text] [Related]
10. Expression of the Topoisomerase II Alpha (top2a) Gene in lung Adenocarcinoma Cells and the Association with Patient Outcomes.
Du X; Xue Z; Lv J; Wang H
Med Sci Monit; 2020 Dec; 26():e929120. PubMed ID: 33361736
[TBL] [Abstract] [Full Text] [Related]
11. Identification of lung adenocarcinoma biomarkers based on bioinformatic analysis and human samples.
Dong S; Men W; Yang S; Xu S
Oncol Rep; 2020 May; 43(5):1437-1450. PubMed ID: 32323809
[TBL] [Abstract] [Full Text] [Related]
12. A panel of autoantibodies against tumor-associated antigens in the early immunodiagnosis of lung cancer.
Jiang D; Wang Y; Liu M; Si Q; Wang T; Pei L; Wang P; Ye H; Shi J; Wang X; Song C; Wang K; Dai L; Zhang J
Immunobiology; 2020 Jan; 225(1):151848. PubMed ID: 31980218
[TBL] [Abstract] [Full Text] [Related]
13. Identification of differentially expressed genes in non-small cell lung cancer.
Wang K; Chen R; Feng Z; Zhu YM; Sun XX; Huang W; Chen ZN
Aging (Albany NY); 2019 Dec; 11(23):11170-11185. PubMed ID: 31816603
[TBL] [Abstract] [Full Text] [Related]
14. Identification and Integrated Analysis of Key Biomarkers for diagnosis and Prognosis of Non-Small Cell lung cancer.
Liu X; Liu X; Li J; Ren F
Med Sci Monit; 2019 Dec; 25():9280-9289. PubMed ID: 31805030
[TBL] [Abstract] [Full Text] [Related]
15. Integrative analysis of mRNA and miRNA expression profiles reveals seven potential diagnostic biomarkers for non‑small cell lung cancer.
Zhang J; Li D; Zhang Y; Ding Z; Zheng Y; Chen S; Wan Y
Oncol Rep; 2020 Jan; 43(1):99-112. PubMed ID: 31746439
[TBL] [Abstract] [Full Text] [Related]
16. Extracting predictors for lung adenocarcinoma based on Granger causality test and stepwise character selection.
Fan X; Wang Y; Tang XQ
BMC Bioinformatics; 2019 May; 20(Suppl 7):197. PubMed ID: 31074380
[TBL] [Abstract] [Full Text] [Related]
17. Tissue-specific selection of optimal reference genes for expression analysis of anti-cancer drug-related genes in tumor samples using quantitative real-time RT-PCR.
Wang H; Yang B; Geng T; Li B; Dai P; Chen C
Exp Mol Pathol; 2015 Jun; 98(3):375-81. PubMed ID: 25445497
[TBL] [Abstract] [Full Text] [Related]
18. Identification of genes whose expression is upregulated in lung adenocarcinoma cells in comparison with type II alveolar cells and bronchiolar epithelial cells in vivo.
Kobayashi K; Nishioka M; Kohno T; Nakamoto M; Maeshima A; Aoyagi K; Sasaki H; Takenoshita S; Sugimura H; Yokota J
Oncogene; 2004 Apr; 23(17):3089-96. PubMed ID: 14755238
[TBL] [Abstract] [Full Text] [Related]
